Episode

Why is the US ending AIDS funding for South Africa?

Podcast
The Global Story
Published
Jun 26, 2026
Duration seconds
1643
Processing state
not_requested
Canonical source
http://www.bbc.co.uk/programmes/w3ct8m8x
Audio
http://open.live.bbc.co.uk/mediaselector/6/redir/version/2.0/mediaset/audio-nondrm-download-rss/proto/http/vpid/p0nv7skq.mp3
JSON
/v1/public/podcasts/the-global-story-6677479/episodes/why-is-the-us-ending-aids-funding-for-south-africa
Markdown
/podcast/the-global-story-6677479/why-is-the-us-ending-aids-funding-for-south-africa.md

Actions

  • POST https://stenobird.com/v1/public/podcasts/the-global-story-6677479/episodes/why-is-the-us-ending-aids-funding-for-south-africa/transcription-requests
    Idempotently request low-priority transcript generation for this episode.
  • GET https://stenobird.com/podcast/the-global-story-6677479/why-is-the-us-ending-aids-funding-for-south-africa.md
    Read the agent-friendly Markdown representation of this episode resource.

Summary

For two decades, PEPFAR, the US program to curb AIDS/HIV, enjoyed support and financial backing from both Republicans and Democrats, saving an estimated 26 million lives in what is described as the largest ever commitment by any nation to address a single disease. Previous presidents - including Donald Trump in his first term - continued to praise and support the effort. But last week, the State Department announced that it would be ending its support for PEPFAR in South Africa. The UN has warned the decision could end up costing lives. US officials told the BBC that the funding cut was in part a response to South Africa's alleged failure to protect the white-minority Afrikaner community, an accusation Pretoria rejects. Asma speaks to the BBC’s Senior Africa Producer Ed Habershon about what drove this decision and what the impact could be. Producers: Cat Farnsworth, Valerio Esposito and Aron Keller Executive producer: Bridget Harney Sound engineer: Travis Evans Digital producer: Richard Kenny Senior news editor: China Collins Photo: Bottles of antiretroviral ARV drugs used to prevent HIV. Credit: Thomas Mukoya/Reuters